By inducing GPR56 gene silencing at different stages of the in vivo tumor xenograft models and examining the final tumor burdens, it was concluded that GPR56 plays a significant role in promoting tumor growth at the early as well as advanced stages of tumor progression. Here, ADGRG1 is linked to neoplasm.